RBOT
Vicarious Surgical Inc.
NYSE · Healthcare · Medical - Devices · US
$0.19
+972.22%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.00
From 52W high−96.84%
Volume13301.00
Market cap$1.15M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataOct 19, 2026
Open
$0.00
From 52W high
−96.84%
Volume
13301.00
Market cap
$1.15M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.1x
P/E (TTM)
—
RSI (14)
67.9
MomentumView details →
1D Return
+972.22%
YTD Return
−91.11%
SummaryUpdated Mar 1, 2026
Vicarious Surgical Inc. (NYSE:RBOT) is a medical device company founded in 2014 and headquartered in Waltham, Massachusetts. The company went public through a SPAC merger in September 2020. Vicarious Surgical is developing revolutionary single-incision surgical robotics technology that aims to transform minimally invasive surgery by virtually transporting surgeons inside the patient's body. The company is currently in the pre-commercial stage, having completed development of its Version 1.0 surgical system and preparing for its first clinical trials in 2025.
Similar companies
Latest newsMore news →
Vicarious Surgical shareholders voted to shut down and liquidate the company immediately.90d agoVicarious Surgical's board of directors proposes to dissolve and liquidate the company, seeking shareholder approval at a special meeting on July 21, 2026.96d agoSarah Romano resigned as Chief Financial Officer of Vicarious Surgical Inc., effective July 22, 2026.118d ago